New immunosuppressive agents: Expectations and controversies.

被引:3
作者
Alsina, J [1 ]
Grinyo, JM [1 ]
机构
[1] Bellvitge Hosp, Barcelona, Spain
关键词
D O I
10.1097/01.TP.0000046766.12404.F9/
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:741 / 742
页数:2
相关论文
共 5 条
[1]   Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primates [J].
Ikonen, TS ;
Gummert, JF ;
Hayase, M ;
Honda, Y ;
Hausen, B ;
Christians, U ;
Berry, GJ ;
Yock, PG ;
Morris, RE .
TRANSPLANTATION, 2000, 70 (06) :969-975
[2]   Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. [J].
Johnson, RWG ;
Kreis, H ;
Oberbauer, R ;
Brattström, C ;
Claesson, K ;
Eris, J .
TRANSPLANTATION, 2001, 72 (05) :777-786
[3]  
KERIS H, 2001, TRANSPLANTATION S, V72, P99
[4]  
MacDonald A, 2001, TRANSPLANTATION, V72, pSS105
[5]  
Podder H, 2001, J AM SOC NEPHROL, V12, P1059, DOI 10.1681/ASN.V1251059